Fig. 4From: Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantationClinical outcomes in patients with MDS-IB subgroup according to disease status at the time of transplantation (N = 121). A Cumulative incidence rate of relapse. B Cumulative incidence rate of NRM. C OS probabilities. D PFS probabilitiesBack to article page